SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 43 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,066 | -15.3% | 3,005,000 | -3.0% | 0.02% | -22.7% |
| Q1 2023 | $5,983 | -31.5% | 3,097,000 | -33.7% | 0.02% | -29.0% |
| Q4 2022 | $8,731 | -100.0% | 4,674,000 | -80.0% | 0.03% | -78.3% |
| Q3 2022 | $39,095,000 | +491.5% | 23,424,000 | +344.7% | 0.14% | +521.7% |
| Q2 2022 | $6,610,000 | -8.1% | 5,267,000 | -3.8% | 0.02% | +21.1% |
| Q1 2022 | $7,194,000 | -89.9% | 5,476,000 | -88.7% | 0.02% | -88.3% |
| Q4 2021 | $71,054,000 | +228.1% | 48,435,000 | +449.0% | 0.16% | +184.2% |
| Q4 2020 | $21,654,000 | +19.2% | 8,823,000 | +0.8% | 0.06% | -1.7% |
| Q3 2020 | $18,167,000 | -51.1% | 8,751,000 | -45.9% | 0.06% | -55.4% |
| Q2 2020 | $37,158,000 | +346.7% | 16,173,000 | +195.3% | 0.13% | +251.4% |
| Q1 2020 | $8,319,000 | +29.1% | 5,477,000 | +12.5% | 0.04% | +68.2% |
| Q3 2019 | $6,446,000 | -65.2% | 4,870,000 | -41.4% | 0.02% | -63.3% |
| Q2 2019 | $18,534,000 | +17.4% | 8,317,000 | -4.6% | 0.06% | +13.2% |
| Q1 2019 | $15,787,000 | – | 8,719,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |